CAS RN: 642459-09-4
2-Chloro-6-(1H-pyrazol-1-yl)pyrazine 95%
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250714
1g / 5g / 25g / 100g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 642459-09-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
642459-09-4 / 2-chloro-6-pyrazol-1-ylpyrazine
Standard CAS: 642459-09-4
Multi CAS: No
Basic Information
copy
CAS
642459-09-4 copy
Multi CAS
No copy
Molecular Formula
C7H5CLN4 copy
Molecular Weight
180.590000 copy
Exact Mass
180.020274 copy
InChI
InChI=1S/C7H5ClN4/c8-6-4-9-5-7(11-6)12-3-1-2-10-12/h1-5H copy
InChIKey
WGFZJZXNZJZULL-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
12 copy
Aromatic heavy atom count
11 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
44.16 copy
TPSA
43.6 copy
LogP / Solubility
WLOGP
1.32 copy
MLOGP
1.16 copy
XLogP3
1 copy
Consensus LogP
1.16 copy
Log S (ESOL)
-2.4 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.99 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-2.05 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.89 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy